SLE vs OPRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

SLE

36.3
AI Score
VS
OPRA Wins

OPRA

55.0
AI Score

Investment Advisor Scores

SLE

36score
Recommendation
AVOID NEW MONEY

OPRA

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SLE OPRA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.3% 24.6% OPRA
Earnings Growth 0.0% 76.5% OPRA
Tradestie Score 36.3/100 55.0/100 OPRA
Profit Margin -190.3% 18.6% OPRA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD OPRA

Relative Price Performance (Last 90 Days)

SLE 1M: +41.3% · 3M: +74.9% OPRA 1M: -4.1% · 3M: -13.8%

Current Technical Phase

SLE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.6% over 20 days), RSI 58

RSI (14): 57.7 · Price: $5.30

OPRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 41

RSI (14): 40.8 · Price: $17.70

Fundamentals Snapshot

Metric SLE OPRA
Market Cap — —
Forward P/E -1.7 9.9
Trailing P/E 0.0 12.8
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.4% 0.5%
Operating Margin -1.2% 0.2%
EPS 114.56 1.38
Dividend Yield — 0.05%

Frequently Asked Questions

Based on our detailed analysis, OPRA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.